BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31446075)

  • 1. New Insights into Beta-Cell GLP-1 Receptor and cAMP Signaling.
    Tomas A; Jones B; Leech C
    J Mol Biol; 2020 Mar; 432(5):1347-1366. PubMed ID: 31446075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Targeted RNAi Screen Identifies Endocytic Trafficking Factors That Control GLP-1 Receptor Signaling in Pancreatic β-Cells.
    Buenaventura T; Kanda N; Douzenis PC; Jones B; Bloom SR; Chabosseau P; Corrêa IR; Bosco D; Piemonti L; Marchetti P; Johnson PR; Shapiro AMJ; Rutter GA; Tomas A
    Diabetes; 2018 Mar; 67(3):385-399. PubMed ID: 29284659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors.
    Jones B; McGlone ER; Fang Z; Pickford P; Corrêa IR; Oishi A; Jockers R; Inoue A; Kumar S; Görlitz F; Dunsby C; French PMW; Rutter GA; Tan T; Tomas A; Bloom SR
    J Biol Chem; 2021; 296():100133. PubMed ID: 33268378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone receptor membrane component 1 is a functional part of the glucagon-like peptide-1 (GLP-1) receptor complex in pancreatic β cells.
    Zhang M; Robitaille M; Showalter AD; Huang X; Liu Y; Bhattacharjee A; Willard FS; Han J; Froese S; Wei L; Gaisano HY; Angers S; Sloop KW; Dai FF; Wheeler MB
    Mol Cell Proteomics; 2014 Nov; 13(11):3049-62. PubMed ID: 25044020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minireview: Signal bias, allosterism, and polymorphic variation at the GLP-1R: implications for drug discovery.
    Koole C; Savage EE; Christopoulos A; Miller LJ; Sexton PM; Wootten D
    Mol Endocrinol; 2013 Aug; 27(8):1234-44. PubMed ID: 23864649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of insulin secretion by GLP-1.
    Jones B; Bloom SR; Buenaventura T; Tomas A; Rutter GA
    Peptides; 2018 Feb; 100():75-84. PubMed ID: 29412835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation.
    Yabe D; Seino Y
    Prog Biophys Mol Biol; 2011 Nov; 107(2):248-56. PubMed ID: 21820006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist-induced membrane nanodomain clustering drives GLP-1 receptor responses in pancreatic beta cells.
    Buenaventura T; Bitsi S; Laughlin WE; Burgoyne T; Lyu Z; Oqua AI; Norman H; McGlone ER; Klymchenko AS; Corrêa IR; Walker A; Inoue A; Hanyaloglu A; Grimes J; Koszegi Z; Calebiro D; Rutter GA; Bloom SR; Jones B; Tomas A
    PLoS Biol; 2019 Aug; 17(8):e3000097. PubMed ID: 31430273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles.
    Bueno AB; Showalter AD; Wainscott DB; Stutsman C; Marín A; Ficorilli J; Cabrera O; Willard FS; Sloop KW
    J Biol Chem; 2016 May; 291(20):10700-15. PubMed ID: 26975372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
    Lee YS; Jun HS
    Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular physiology of glucagon-like peptide-1 insulin secretagogue action in pancreatic β cells.
    Leech CA; Dzhura I; Chepurny OG; Kang G; Schwede F; Genieser HG; Holz GG
    Prog Biophys Mol Biol; 2011 Nov; 107(2):236-47. PubMed ID: 21782840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New screening strategy and analysis for identification of allosteric modulators for glucagon-like peptide-1 receptor using GLP-1 (9-36) amide.
    Nakane A; Gotoh Y; Ichihara J; Nagata H
    Anal Biochem; 2015 Dec; 491():23-30. PubMed ID: 26341912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical assessment of glucagon-like peptide 1 receptor (GLP-1R) expression in the pancreas of patients with type 2 diabetes.
    Kirk RK; Pyke C; von Herrath MG; Hasselby JP; Pedersen L; Mortensen PG; Knudsen LB; Coppieters K
    Diabetes Obes Metab; 2017 May; 19(5):705-712. PubMed ID: 28094469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide-1 receptor is present in pancreatic acinar cells and regulates amylase secretion through cAMP.
    Hou Y; Ernst SA; Heidenreich K; Williams JA
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G26-33. PubMed ID: 26542397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acylation of the Incretin Peptide Exendin-4 Directly Impacts Glucagon-Like Peptide-1 Receptor Signaling and Trafficking.
    Lucey M; Ashik T; Marzook A; Wang Y; Goulding J; Oishi A; Broichhagen J; Hodson DJ; Minnion J; Elani Y; Jockers R; Briddon SJ; Bloom SR; Tomas A; Jones B
    Mol Pharmacol; 2021 Oct; 100(4):319-334. PubMed ID: 34315812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide 1-potentiated insulin secretion and proliferation of pancreatic β-cells.
    Ma X; Guan Y; Hua X
    J Diabetes; 2014 Sep; 6(5):394-402. PubMed ID: 24725840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'.
    Skow MA; Bergmann NC; Knop FK
    Diabetes Obes Metab; 2016 Sep; 18(9):847-54. PubMed ID: 27160961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Interplay of Glucagon-Like Peptide-1 Receptor Trafficking and Signalling in Pancreatic Beta Cells.
    Marzook A; Tomas A; Jones B
    Front Endocrinol (Lausanne); 2021; 12():678055. PubMed ID: 34040588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.
    Lamont BJ; Li Y; Kwan E; Brown TJ; Gaisano H; Drucker DJ
    J Clin Invest; 2012 Jan; 122(1):388-402. PubMed ID: 22182839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel extrapancreatic effects of incretin.
    Yamada Y; Tsukiyama K; Sato T; Shimizu T; Fujita H; Narita T
    J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):76-9. PubMed ID: 27186360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.